Very high remission rates are achieved by methotrexate and intraarticular glucocorticoids independent of induction therapy with adalimumab: Year 2 clinical results of an investigator-initiated randomised, controlled clinical trial of early, rheumatoid arthritis

Kim Hørslev-Petersen; Merete Lund Hetland; P. Junker; Jan Pødenphanth; T. Ellingsen; P. Ahlqvist; H.M. Lindegaard; A. Linauskas; A. Schlemmer; M.Y. Dam; I. Hansen; T. Lottenburger; A. Jørgensen; Sophine Boysen Krintel; J. Raun; C.G. Ammitzbøll; Julia Sidenius Johansen; Mikkel Østergaard

Very high remission rates are achieved by methotrexate and intraarticular glucocorticoids independent of induction therapy with adalimumab: Year 2 clinical results of an investigator-initiated randomised, controlled clinical trial of early, rheumatoid arthritis

Kim Hørslev-Petersen, Merete Lund Hetland, P. Junker, Jan Pødenphanth, T. Ellingsen, P. Ahlqvist, H.M. Lindegaard, A. Linauskas, A. Schlemmer, M.Y. Dam, I. Hansen, T. Lottenburger, A. Jørgensen, Sophine Boysen Krintel, J. Raun, C.G. Ammitzbøll, Julia Sidenius Johansen, Mikkel Østergaard

Originalsprog	Engelsk
Tidsskrift	Arthritis & Rheumatism
Vol/bind	65
Udgave nummer	Suppl. 10
Sider (fra-til)	S1148
Antal sider	1
ISSN	0004-3591
Status	Udgivet - 2013

Citationsformater

Hørslev-Petersen, K., Hetland, M. L., Junker, P., Pødenphanth, J., Ellingsen, T., Ahlqvist, P., Lindegaard, H. M., Linauskas, A., Schlemmer, A., Dam, M. Y., Hansen, I., Lottenburger, T., Jørgensen, A., Krintel, S. B., Raun, J., Ammitzbøll, C. G., Johansen, J. S., & Østergaard, M. (2013). Very high remission rates are achieved by methotrexate and intraarticular glucocorticoids independent of induction therapy with adalimumab: Year 2 clinical results of an investigator-initiated randomised, controlled clinical trial of early, rheumatoid arthritis. Arthritis & Rheumatism, 65(Suppl. 10), S1148.

Very high remission rates are achieved by methotrexate and intraarticular glucocorticoids independent of induction therapy with adalimumab: Year 2 clinical results of an investigator-initiated randomised, controlled clinical trial of early, rheumatoid arthritis. / Hørslev-Petersen, Kim; Hetland, Merete Lund; Junker, P. et al.
I: Arthritis & Rheumatism, Bind 65, Nr. Suppl. 10, 2013, s. S1148.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Hørslev-Petersen, K, Hetland, ML, Junker, P, Pødenphanth, J, Ellingsen, T, Ahlqvist, P, Lindegaard, HM, Linauskas, A, Schlemmer, A, Dam, MY, Hansen, I, Lottenburger, T, Jørgensen, A, Krintel, SB, Raun, J, Ammitzbøll, CG, Johansen, JS & Østergaard, M 2013, 'Very high remission rates are achieved by methotrexate and intraarticular glucocorticoids independent of induction therapy with adalimumab: Year 2 clinical results of an investigator-initiated randomised, controlled clinical trial of early, rheumatoid arthritis', Arthritis & Rheumatism, bind 65, nr. Suppl. 10, s. S1148.

Hørslev-Petersen K, Hetland ML, Junker P, Pødenphanth J, Ellingsen T, Ahlqvist P et al. Very high remission rates are achieved by methotrexate and intraarticular glucocorticoids independent of induction therapy with adalimumab: Year 2 clinical results of an investigator-initiated randomised, controlled clinical trial of early, rheumatoid arthritis. Arthritis & Rheumatism. 2013;65(Suppl. 10):S1148.

Hørslev-Petersen, Kim ; Hetland, Merete Lund ; Junker, P. et al. / Very high remission rates are achieved by methotrexate and intraarticular glucocorticoids independent of induction therapy with adalimumab: Year 2 clinical results of an investigator-initiated randomised, controlled clinical trial of early, rheumatoid arthritis. I: Arthritis & Rheumatism. 2013 ; Bind 65, Nr. Suppl. 10. s. S1148.

@article{83dc7138d09a4c789b01148d77f392e6,

title = "Very high remission rates are achieved by methotrexate and intraarticular glucocorticoids independent of induction therapy with adalimumab: Year 2 clinical results of an investigator-initiated randomised, controlled clinical trial of early, rheumatoid arthritis",

author = "Kim H{\o}rslev-Petersen and Hetland, {Merete Lund} and P. Junker and Jan P{\o}denphanth and T. Ellingsen and P. Ahlqvist and H.M. Lindegaard and A. Linauskas and A. Schlemmer and M.Y. Dam and I. Hansen and T. Lottenburger and A. J{\o}rgensen and Krintel, {Sophine Boysen} and J. Raun and C.G. Ammitzb{\o}ll and Johansen, {Julia Sidenius} and Mikkel {\O}stergaard",

year = "2013",

language = "English",

volume = "65",

pages = "S1148",

journal = "Arthritis & Rheumatism",

issn = "0004-3591",

publisher = "John/Wiley & Sons, Inc. John/Wiley & Sons Ltd",

number = "Suppl. 10",

}

TY - ABST

T1 - Very high remission rates are achieved by methotrexate and intraarticular glucocorticoids independent of induction therapy with adalimumab: Year 2 clinical results of an investigator-initiated randomised, controlled clinical trial of early, rheumatoid arthritis

AU - Hørslev-Petersen, Kim

AU - Hetland, Merete Lund

AU - Junker, P.

AU - Pødenphanth, Jan

AU - Ellingsen, T.

AU - Ahlqvist, P.

AU - Lindegaard, H.M.

AU - Linauskas, A.

AU - Schlemmer, A.

AU - Dam, M.Y.

AU - Hansen, I.

AU - Lottenburger, T.

AU - Jørgensen, A.

AU - Krintel, Sophine Boysen

AU - Raun, J.

AU - Ammitzbøll, C.G.

AU - Johansen, Julia Sidenius

AU - Østergaard, Mikkel

PY - 2013

Y1 - 2013

M3 - Conference abstract in journal

SN - 0004-3591

VL - 65

SP - S1148

JO - Arthritis & Rheumatism

JF - Arthritis & Rheumatism

IS - Suppl. 10

ER -